| Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939) |
|---|
| 07/21/2004 | CN1158260C Solid compound, preparation method therefor and use in medicine |
| 07/21/2004 | CN1158258C Alpha 1 beta-adrenergic receptor antagonists |
| 07/21/2004 | CN1158107C Pharmaceutical compositions contg. platelet aggregation inhibitors |
| 07/20/2004 | US6765009 1,4-Disubstituted benzo-fused compounds |
| 07/15/2004 | WO2004058736A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058711A1 Isolation of dihydropyridine derivative and preparation salts thereof |
| 07/15/2004 | WO2004058710A1 Novel benzamide derivatives and process for production thereof |
| 07/15/2004 | WO2004058709A1 Ccr8 inhibitors |
| 07/15/2004 | WO2004058705A2 Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 07/15/2004 | WO2004058700A2 Mitotic kinesin inhibitors |
| 07/15/2004 | WO2004058686A1 Hydroxypropyl amides for the treatment of alzheimer’s disease |
| 07/15/2004 | WO2004058148A2 Mitotic kinesin inhibitors |
| 07/15/2004 | WO2004045536A3 Method and compositions for temporarily incapaciting subjets |
| 07/15/2004 | WO2004041163A3 Piperidinyl cyclopentyl aryl benzylamide modulators of chemokine receptor activity |
| 07/15/2004 | WO2004039753A3 Phenyl compounds |
| 07/15/2004 | WO2004005478A2 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/15/2004 | WO2003075836A3 Cathepsin cysteine protease inhibitors |
| 07/15/2004 | US20040138462 Aminoalcohol derivatives |
| 07/15/2004 | US20040138461 Methods for the syntheses of alfentanil sufentanil and remifentanil |
| 07/15/2004 | US20040138452 Discoloration inhibition, colorfastness for candle wax; polymers |
| 07/15/2004 | US20040138281 Parkinson's and Huntington's disease; psychoses, impotence, renal or heart failure, schizophrenia |
| 07/15/2004 | US20040138275 Serine protease inhibitor; cardiovascular disorders |
| 07/15/2004 | US20040138259 Pain management |
| 07/15/2004 | US20040138228 Novel compounds with analgesic effect |
| 07/15/2004 | US20040138220 Central nervous system disorder; gastrointestinal disorders; asthma; skin disorders; inflammatory bowel disorders; analgesics |
| 07/15/2004 | US20040138205 Viricides; hepatitis virus |
| 07/15/2004 | DE10300112A1 Fluorierungsreagenzien und Verfahren zu deren Herstellung Fluorinating reagents and methods for their preparation |
| 07/15/2004 | CA2511989A1 Novel benzamide derivatives and process for producing the same |
| 07/15/2004 | CA2509212A1 Mitotic kinesin inhibitors |
| 07/15/2004 | CA2508956A1 Mitotic kinesin inhibitors |
| 07/15/2004 | CA2489590A1 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 07/14/2004 | EP1437346A1 Benzamide derivatives useful as cell differentiation inducers |
| 07/14/2004 | EP1437344A1 Benzene derivatives,process for preparing the same and use thereof |
| 07/14/2004 | EP1437342A2 Fluorinating reactants and process for their preparation |
| 07/14/2004 | EP1436284A1 Synthesis of 4- (z)-(4-bromophenyl)(ethoxyimino)methyl]-1'- 2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl]-4'methyl-1,4'bipiperidine |
| 07/14/2004 | EP1436281A1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/14/2004 | EP1436280A1 A process for preparing 4-(hydroxy)- 1,4']bipiperidinyl-l'carboxylic acid tert-butyl ester |
| 07/14/2004 | EP1436271A1 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 07/14/2004 | EP1436262A1 Synthesis of (4-bromophenyl) (4-piperidyl)methanone-(z)-o-ethyloxime and salts |
| 07/14/2004 | EP1436253A1 Acylsulfonamides as inhibitors of steroid sulfatase |
| 07/14/2004 | EP1435955A2 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/14/2004 | EP1435954A1 High purity amlodipine benzenesulfonate and a process for its preparation |
| 07/14/2004 | EP1435942A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 07/14/2004 | EP1235803B1 Urea compounds having muscarinic receptor antagonist activity |
| 07/14/2004 | EP1144368B1 Acetylenic alpha-amino acid-based sulfonamide hydroxamic acid tace inhibitors |
| 07/14/2004 | EP1077940B1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 07/14/2004 | EP0901468B1 Preparation of lactams from aliphatic alpha,omega-dinitriles |
| 07/14/2004 | CN1512983A Compounds and compositions as cathepsins inhibitors |
| 07/14/2004 | CN1157376C Arylpiperidinopropanol and arylpiperaznipropanol derivatives and pharmaceuticals containing the same |
| 07/14/2004 | CN1157365C Monoamine reuptake inhibitors for treatment of CNS disorders |
| 07/14/2004 | CN1157224C Novel amide derives. as growth hormone secretagogues |
| 07/13/2004 | US6762330 Making biaryls by reacting a grignard reagent and an aryl halide in the presence of a transition metal complex with a phosphine oxide or phosphine sulfoxide (hp(=s) type) as catalyst |
| 07/13/2004 | US6762187 Heterocyclic nitrogen compounds used as enzyme inhibitors for prophylaxis of human immunodeficiency virus(hiv) |
| 07/13/2004 | US6762175 Fatty acid derivatives |
| 07/13/2004 | CA2244771C Substituted 3-aryl-3-carboxyalkyl glutaramides, method for preparing same, and use thereof |
| 07/13/2004 | CA2155020C Antiviral naphthoquinone compounds, compositions and uses thereof |
| 07/08/2004 | WO2004056809A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056808A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056774A2 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | WO2004056773A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/08/2004 | WO2004056772A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as tachykinin antagonists |
| 07/08/2004 | WO2004056771A1 Piperidine amine compounds and their use |
| 07/08/2004 | WO2004056751A1 Antibacterial agents |
| 07/08/2004 | WO2004056364A1 Substituted 1-piperidin-3-yl-4-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 07/08/2004 | WO2004056319A2 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | WO2003062181A8 PROCESS FOR THE PREPARATION OF NONRACEMIC SYN-1-(4-HYDROXY-PHENYL)-2-(4-HYDROXY-4-PHENYL.PIPERIDIN-1Yl)-1-PROPANOL COMPOUNDS |
| 07/08/2004 | US20040132809 Cell adhesion inhibitors |
| 07/08/2004 | US20040132744 lower gastrointestinal and cardiovascular side effects; use in treatment of respiratory system disorders, as tokolitics and as antiallergics, for eye applications. |
| 07/08/2004 | US20040132736 17 Beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132718 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| 07/08/2004 | US20040132717 2-Oxo-piperidinyl-and 2-oxo-azepanyl alkanoic acid derivatives for the treatment of epilepsy and other neurological disorders |
| 07/08/2004 | US20040132713 Fluorinated cyclic amides as dipeptidyl peptidase IV inhibitors |
| 07/08/2004 | US20040129178 Contains no additional light stabilizer, therefore, side effects caused by the addition of a light stabilizer, such as precipitate generation, may be prevented |
| 07/08/2004 | CA2510471A1 Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators |
| 07/08/2004 | CA2509881A1 Substituted n-phenyl sulfonamide bradykinin antagonists |
| 07/08/2004 | CA2508624A1 Novel piperidine derivatives as modulators of chemokine receptor ccr5 |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | EP1434819A2 Fluorescent pigment composition |
| 07/07/2004 | EP1434769A2 Compounds useful as reversible inhibitors of cysteine proteases |
| 07/07/2004 | EP1434766A1 Piperidine compounds as muscarinic antagonists |
| 07/07/2004 | EP1434765A1 Substituted piperidines with selective binding to histamine h3-receptor |
| 07/07/2004 | EP1434764A2 Process for obtainment of enantiomers-of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; process for obtainment of non-racemic mixtures between the enantiomers of n-(2,6-dimethylphenyl)-1-propyl-2-piperidinocarboxamide; compound consisting of non-racemic mixtures of enantiomers of n-(2,6-d |
| 07/07/2004 | EP1121347B1 Process for the synthesis of 4-substituted n- (alk-2- en-1-yl)oxy]- and n-aralkyloxy- 2,2,6,6- tetraalkylpiperidines |
| 07/07/2004 | EP0892827B1 Stabilizer composition |
| 07/07/2004 | CN1511151A 3-quinoline-2-(1H)-ylideneindolin-2-one derivatives |
| 07/07/2004 | CN1156448C Optical isomer of 3-methyl fentanyl, derivant, synthesizing and its analgesic activity |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759430 Piperidine and pyrrolidine derivatives comprising a nitric oxide donor for treating stress |
| 07/06/2004 | US6759420 Low molecular weight, factor xa specific blood clotting inhibitors without side effects |
| 07/06/2004 | US6759411 Heterocyclic piperidines as modulators of chemokine receptor activity |
| 07/01/2004 | WO2004055012A1 Indane compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055010A2 Cyclopropyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004055006A1 Novel compounds having selective inhibiting effect at gsk3 |
| 07/01/2004 | WO2004054973A2 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor |
| 07/01/2004 | WO2004054955A1 Process for the preparation of fexofenadine |
| 07/01/2004 | WO2004054581A2 Cyclohexyl compounds as ccr5 antagonists |
| 07/01/2004 | WO2004033426A3 Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents |
| 07/01/2004 | WO2004031145A3 Lactam-containing diaminoalkyl, beta-aminoacids, alpha-aminoacids and derivatives thereof as factor xa inhibitors |
| 07/01/2004 | WO2004018644A3 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |